TAOX Stock Chart & Stats
$4.97
--
Market closed
$4.97
--
Day’s Range― - ―
52-Week Range$3.30 - $11.98
Previous CloseN/A
VolumeN/A
Average Volume (3M)327.04K
Market Cap
$26.75M
Enterprise Value$8.97M
Total Cash (Recent Filing)$28.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.79
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,471,931
10 Day Avg. Volume507,712
30 Day Avg. Volume327,041
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.55
Price to Sales (P/S)40.61
P/FCF Ratio-1.90
Enterprise Value/Market Cap0.34
Enterprise Value/Revenue13.05
Enterprise Value/Gross Profit13.05
Enterprise Value/Ebitda-0.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tao Synergies News
TAOX FAQ
What was Tao Synergies’s price range in the past 12 months?
Tao Synergies lowest stock price was $3.30 and its highest was $11.98 in the past 12 months.
What is Tao Synergies’s market cap?
Tao Synergies’s market cap is $26.75M.
When is Tao Synergies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tao Synergies’s earnings last quarter?
Currently, no data Available
Is Tao Synergies overvalued?
According to Wall Street analysts Tao Synergies’s price is currently Overvalued.
Does Tao Synergies pay dividends?
Tao Synergies does not currently pay dividends.
What is Tao Synergies’s EPS estimate?
Tao Synergies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tao Synergies have?
Tao Synergies has 7,471,931 shares outstanding.
What happened to Tao Synergies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tao Synergies?
Currently, no hedge funds are holding shares in TAOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tao Synergies
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
Technical Analysis
Vyome Holdings
―
Collplant Holdings
―
SAB Biotherapeutics
―
Neurosense Therapeutics Ltd.
―
Cadrenal Therapeutics, Inc.
―
Ownership Overview
2.36% Insiders
1.67% Mutual Funds
0.58% Other Institutional Investors
94.18% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---